# Glutathione Decrement Drives Thermogenic Program In Adipose Cells

**Authors:** Daniele Lettieri Barbato, Giuseppe Tatulli, Stefano Maria Cannata, Sergio Bernardini, Katia Aquilano, Maria R. Ciriolo

PMC · DOI: 10.1038/srep13091 · Scientific Reports · 2015-08-11

## TL;DR

Reducing glutathione in fat cells triggers a thermogenic response, potentially offering a new way to combat obesity.

## Contribution

This study identifies glutathione decrement as a driver of thermogenic program activation in adipose cells.

## Key findings

- GSH depletion via BSO mimics cold exposure by inducing thermogenic gene expression and uncoupling respiration.
- GSH ester prevents thermogenic activation, confirming GSH decrement's role in the process.
- FoxO1 activation is essential for the browning of white adipocytes triggered by GSH depletion.

## Abstract

Adipose tissue metabolically adapts to external stimuli. We demonstrate that the induction of the thermogenic program in white adipocytes, through cold exposure in mice or in vitro adrenergic stimulation, is accompanied by a decrease in the intracellular content of glutathione (GSH). Moreover, the treatment with a GSH depleting agent, buthionine sulfoximine (BSO), recapitulates the effect of cold exposure resulting in the induction of thermogenic program. In particular, BSO treatment leads to enhanced uncoupling respiration as demonstrated by increased expression of thermogenic genes (e.g. Ucp1, Ppargc1a), augmented oxygen consumption and decreased mitochondrial transmembrane potential. Buffering GSH decrement by pre-treatment with GSH ester prevents the up-regulation of typical markers of uncoupling respiration. We demonstrate that FoxO1 activation is responsible for the conversion of white adipocytes into a brown phenotype as the “browning” effects of BSO are completely abrogated in cells down-regulating FoxO1. In mice, the BSO-mediated up-regulation of uncoupling genes results in weight loss that is at least in part ascribed to adipose tissue mass reduction. The induction of thermogenic program has been largely proposed to counteract obesity-related diseases. Based on these findings, we propose GSH as a novel therapeutic target to increase energy expenditure in adipocytes.

## Linked entities

- **Genes:** UCP1 (uncoupling protein 1) [NCBI Gene 7350], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], FOXO1 (forkhead box O1) [NCBI Gene 2308]
- **Chemicals:** glutathione (PubChem CID 124886), buthionine sulfoximine (PubChem CID 21157)
- **Diseases:** obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Camp (cathelicidin antimicrobial peptide) [NCBI Gene 12796] {aka CAP18, CLP, Cnlp, Cramp, FALL39, MCLP}, Cebpb (CCAAT/enhancer binding protein beta) [NCBI Gene 12608] {aka C/EBPbeta, CRP2, IL-6DBP, LAP, LIP, NF-IL6}, Slc1a3 (solute carrier family 1 (glial high affinity glutamate transporter), member 3) [NCBI Gene 20512] {aka B430115D02Rik, Eaat1, GLAST, GLAST-1, GLU-T, GluT-1}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, Fgf21 (fibroblast growth factor 21) [NCBI Gene 56636] {aka Fgf8c}, Sod2 (superoxide dismutase 2, mitochondrial) [NCBI Gene 20656] {aka MnSOD, Sod-2}, Slc2a4 (solute carrier family 2 (facilitated glucose transporter), member 4) [NCBI Gene 20528] {aka GT2, Glut-4, Glut4, twgy}, Cidea (cell death-inducing DNA fragmentation factor, alpha subunit-like effector A) [NCBI Gene 12683], FNDC5 (fibronectin type III domain containing 5) [NCBI Gene 252995] {aka FRCP2, irisin}, Ucp1 (uncoupling protein 1 (mitochondrial, proton carrier)) [NCBI Gene 22227] {aka Slc25a7, Ucp}, Ucp2 (uncoupling protein 2 (mitochondrial, proton carrier)) [NCBI Gene 22228] {aka Slc25a8, UCP 2, UCPH}, Foxo1 (forkhead box O1) [NCBI Gene 56458] {aka Afxh, FKHR, Fkhr1, Foxo1a}, Gclm (glutamate-cysteine ligase, modifier subunit) [NCBI Gene 14630] {aka Gcmc, Glclr}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Hcrt (hypocretin) [NCBI Gene 15171] {aka PPOX}, Ucp3 (uncoupling protein 3 (mitochondrial, proton carrier)) [NCBI Gene 22229] {aka Slc25a9, UCP-3}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Dio2 (deiodinase, iodothyronine, type II) [NCBI Gene 13371] {aka 5DII, DIOII}, FOXO1 (forkhead box O1) [NCBI Gene 2308] {aka FKH1, FKHR, FOXO1A}
- **Diseases:** inflammation (MESH:D007249), insulin resistance (MESH:D007333), adipose tissue mass reduction (MESH:D018205), cervical dislocation (MESH:D002575), weight loss (MESH:D015431), diabetes (MESH:D003920), metabolic diseases (MESH:D008659), cancer (MESH:D009369), mitochondrial (MESH:D028361), obese (MESH:D009765), weight gain (MESH:D015430), fat (MESH:D004620), toxicity (MESH:D064420), atrophy (MESH:D001284)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** 3F — Homo sapiens (Human), Transformed cell line (CVCL_LJ44), T37i — Mus musculus (Mouse), Mouse hibernoma, Transformed cell line (CVCL_S893), C57/BL6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4531326/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4531326/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC4531326/full.md

---
Source: https://tomesphere.com/paper/PMC4531326